NTRR: Colorado Cannabis Market Worth Nearly $1 Billion

Neutra Corp. (OTCQB: NTRR) continues to build and nurture business relationships in the North American cannabis industry, targeting Colorado as an especially crucial marketplace. And with good reason: The state’s Department of Revenue reported this month that Colorado’s cumulative cannabis sales came in just under $1 billion last year.

That’s an astonishing figure, particularly considering that Colorado only began selling adult-use cannabis a little more than two years ago. Although The Motley Fool reports that medicinal cannabis sales grew by 5.8 percent in 2015 to $408.4 million, the big jump in sales occurred in the adult-use market. Those sales rose from $313.2 million in 2014 to $587.8 million in 2015—an unprecedented 87.7-percent increase.

“There’s little question that Colorado’s cannabis industry will surpass $1 billion this year, and it probably won’t be close,” said NTRR CEO Chris Brown. “Clearly, there is huge demand for cannabis in the state, and it’s one of the most important cannabis marketplaces in all of North America. The growth of the market there is excellent news for the industry.”

Through its joint venture partners Surface to Air Solutions (S2O2) and Green Mountain Plant Health, LLC, NTRR continues to offer new and better products to assist businesses and consumers in the cannabis industry, including an air-scrubber and a self-cleaning hard surface treatment that can help indoor crops thrive without the use of pesticides and fungicides. Some are already in use by growers in Colorado. The company is also working with another joint venture partner, Oceanview Health Services Ltd., to launch a new line of topical cannabis products in North American markets this year.

About Neutra Corp.

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how they grow, what they grow, and how they consume cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, NTRR is constantly combing the industry for the latest and greatest to test, prove and bring to market.

By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA) and 22nd Century Group, Inc. (NYSE: XXII). For investing information and performance data, please visit www.neutrainc.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160301005937/en/